Euthyroid Graves' ophthalmopathy with negative autoantibodies

Journal of the National Medical Association

Volumn 97, Issue 11, 2005, Pages 1547-1549

  Cakir, Mehtap ^a,b,c  

^a Meram School of Medicine ^*

^b SELCUK UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Euthyroid Graves' ophthalmopathy; Thyroid autoantibodies

Indexed keywords

AUTOANTIBODY; THYROID ANTIBODY; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL FEATURE; ENDOCRINE OPHTHALMOPATHY; FEMALE; HUMAN; HYPERTHYROIDISM; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; AUTOANTIBODIES; EXOPHTHALMOS; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 27844571894     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Maciel LM, Rodrigues SS, Dibbern RS, et al. Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds. Thyroid. 2001;11:31-35.
2. Orhan Y, Azezli A, Carin M, et al. Human lymphocyte antigens (HLA) and Graves' disease in Turkey. Clin Immunol. 1993;13:339-343.
3. Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev. 2003;24:802-835.
4. Alper MG, Wartofsky L. Endocrine ophthalmopathy. In: Becker KL, ed. Principles and Practice of Endocrinology and Metabolism. Philadelphia: Lippincott Williams & Wilkins; 2001:428-440.
5. de Juan E Jr, Hurley DP, Sapira JD. Racial differences in normal values of proptosis. Arch Intern Med. 1980;140:1230-1231.
6. Tellez M, Cooper J, Edmonds C. Graves' ophthalmopathy in relation to cigarette smoking and ethnic origin. Clin Endocrinol. 1992;36:291-294.
7. Thyroid Autoantibodies. Laboratory Medicine Practice Guidelines, Laboratory Support For The Diagnosis of Thyroid Disease. Washington, DC: 2003:46-58.
8. Noh JY, Hamada N, Inoue Y, et al. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease. Thyroid. 2000;10:809-813.
9. Goh SY, Ho SC, Seah LL, et al. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease. Clin Endocrinol. 2004;60:600-607.
10. Gerding MN, van der Meer JWC, Broenink M, et al. Association of thyrotropin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin Endocrinol. 2000;52:267-271.
11. Khoo DH, Ho SC, Seah LL, et al. The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy. Thyroid. 1999;9:1175-1180.
12. Kim WB, Chung HK, Park YJ, et al. Clinical significance of Graves' disease according to the characteristics of TSH receptor antibodies. Korean J Intern Med. 2001;16:187-200.
13. Kim WB, Chung HK, Park YJ, et al. The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease. Thyroid. 2001;10:579-586.
14. Khoo DH, Eng PH, Ho SC, et al. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels. Thyroid. 2000;10:1093-1100.
15. Ealey PA, Marshall NJ, Lawton N, et al. The application of a cytochemical bioassay to measure thyroid stimulating antibodies: a study of patients with euthyroid Graves' ophthalmopathy. J Endocrinol Invest. 1984;7:597-602.
16. Watanabe M, Iwatani Y, Kashiwai T, et al. Euthyroid Graves' disease showing no thyroid abnormalities except positive thyroid-stimulating antibody (TSAb): two case reports. J Intern Med. 1995;238:379-384.
17. Costagliola S, Morgenthaler NG, Hoermann R, et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endoc Metab. 1999;84:90-97.